Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
Oost, T.K., Sun, C., Armstrong, R.C., Al-Assaad, A.S., Betz, S.F., Deckwerth, T.L., Ding, H., Elmore, S.W., Meadows, R.P., Olejniczak, E.T., Oleksijew, A.K., Oltersdorf, T., Rosenberg, S.H., Shoemaker, A.R., Tomaselli, K.J., Zou, H., Fesik, S.W.(2004) J Med Chem 47: 4417-4426
- PubMed: 15317454 
- DOI: 10.1021/jm040037k
- Primary Citation of Related Structures:  
1TFQ, 1TFT - PubMed Abstract: 
Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been implicated in tumor growth, pathogenesis, and resistance to chemo- or radiotherapy. On the basis of the NMR structure of a SMAC peptide complexed with the BIR3 domain of X-linked IAP (XIAP), a novel series of XIAP antagonists was discovered ...